What OTX Force does

OTX Force GmbH is the independent, wholly-owned sales and distribution subsidiary of the Dr. Willmar Schwabe Group, a 5th-generation, family-owned German pharmaceutical group founded in 1866 that is positioned as a worldwide leading expert in phytopharmaceuticals (herbal medicines). Headquartered in Karlsruhe, Germany (Willmar-Schwabe-Str. 4, 76227 Karlsruhe), OTX Force is staffed at 51–100 employees (firmographic signal) and exists specifically as the group's eigenständige Vertriebsgesellschaft — a focused sales organization that markets the parent group's herbal medicinal products to physicians (Ärzte) and pharmacists (Apotheker) in Germany.

The company's product portfolio comprises five core phytopharmaceutical brands owned and manufactured by parent Schwabe: Lasea (lavender oil for restlessness with anxious mood), Tebonin konzent 240 mg (Ginkgo-biloba leaf extract for mild dementia), Umckaloabo (Pelargonium-sidoides root extract for acute bronchitis, a registered trademark), Carmenthin (for dyspeptic complaints and gastrointestinal discomfort), and Refluthin. The parent group controls the full production chain from seedling cultivation to finished packaged medicine in pharmacies, providing OTX Force with a vertically integrated, regulated supply of evidence-based herbal products.

OTX Force operates a B2B2C go-to-market: a dedicated, medically-trained field sales force consults German doctors and pharmacists on phytopharmaceutical therapy, knowledge transfer, and evidence-based personalized medicine support, with the downstream patient consumer reached via pharmacy dispensing and physician recommendation. Revenue is generated through one-time product sales of prescription and OTC herbal medicines through German pharmacies (Apotheken); no direct revenue figures, subscription, or licensing economics are disclosed. The company supplements its field-sales motion with multi-channel digital and social engagement (LinkedIn, Facebook, X, XING, Instagram, Pinterest, YouTube, Google Ads, email newsletter, Google Analytics). OTX Force is privately held, has no funding history, and operates under the legal entity OTX Force GmbH (HRB 723850, Registergericht Mannheim).

Name

OTX Force

Legal name

OTX Force GmbH

Website

https://otx-force.de

Company type

Private

Operating status

Operating

Headcount range

51–100 employees

Short description

OTX Force GmbH is the dedicated German sales subsidiary of family-owned Dr. Willmar Schwabe Group, marketing five evidence-based phytopharmaceutical brands (Lasea, Tebonin, Umckaloabo, Carmenthin, Refluthin) to physicians and pharmacists across Germany via a specialized field-sales motion and pharmacy distribution.

Ownership category

akta.pro rank

Product category

Phytopharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Sleep, Stress & Mood Support (HLAIADAG)

akta.pro secondary industry

Cold, Flu & Cough Remedies (HLAIADAB)

Keywords

• Herbal medicines
• Phytopharmaceutical distribution
• Plant-based pharmaceuticals
• Pharmacy sales force
• Germany healthcare distribution

Headquarters

HQ city

Ettlingen

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations, Supply Chain

Revenue model

1. Phytopharmaceutical product sales: Sales of herbal medicines (Phytopharmaka) including Lasea, Tebonin, Umckaloabo, Carmenthin, and Refluthin through pharmacies and healthcare providers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels10 records

Core offering

OTX Force GmbH is the independent sales and distribution company of the Dr. Willmar Schwabe Group for the German market. It markets and distributes a portfolio of phytopharmaceutical (herbal) medicines—including Lasea, Tebonin, Umckaloabo, Carmenthin, and Refluthin—to doctors (Ärzte) and pharmacists (Apotheker), providing medical-pharmaceutical consultation and knowledge transfer about plant-based therapies.

Product overview

OTX Force GmbH is the independent sales company of the Dr. Willmar Schwabe Group, specializing in the marketing and distribution of herbal/phytopharmaceutical medicines (Phytopharmaka) to doctors and pharmacists in Germany. The company offers a portfolio of five core herbal medicine products: Lasea (lavender oil for anxiety), Tebonin konzent 240 mg (Ginkgo biloba for mild dementia), Umckaloabo (Pelargonium sidoides for acute bronchitis), Carmenthin (for digestive disorders), and Refluthin. The company emphasizes natural, plant-based medicines with high efficacy and good tolerability, backed by extensive research and development from the Schwabe Group, which is a globally leading expert in herbal pharmaceuticals.

Differentiator

Problem solved

Functional benefit

Brands

• Lasea: Herbal medicinal product with lavender oil (Lavendelöl) for treatment of restlessness with anxious mood.
• Tebonin konzent 240 mg
• Umckaloabo
• Carmenthin
• Refluthin

Products and services

• Lasea
• Tebonin konzent 240 mg
• Umckaloabo
• Carmenthin bei Verdauungsstörungen
• Refluthin

Named customers2 records

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Dr. Willmar Schwabe GroupcoreOthersOTX Force GmbH is a wholly-owned subsidiary (100-prozentiges Tochterunternehmen) of the Dr. Willmar Schwabe Group. The parent company is the worldwide leading expert in researching, developing, and manufacturing herbal medicines, managed in its fifth generation as a family-owned business. OTX Force serves as the independent sales company (Vertriebsgesellschaft) of the group, responsible for marketing and sales of Dr. Willmar Schwabe products in Germany.

Scale indicators3 records

Recent moves7 records

Expansion highlights3 records

Regional players

• Caelo GmbH: A German supplier of herbal raw materials, extracts, and galenic intermediates used by phytopharmaceutical manufacturers in Germany. Comparable as a regional herbal-medicine ecosystem participant serving the same Schwabe/Bionorica-style phytopharma supply chain.

Direct peers

• Bionorica SE: A German family-owned pharmaceutical company specializing in evidence-based phytopharmaceuticals (e.g., Sinupret, Bronchipret). Closely comparable to OTX Force/Schwabe in therapeutic areas such as respiratory and in targeting physicians and pharmacists in Germany with clinically researched herbal medicines.
• Biologische Heilmittel Heel GmbH: A German pharmaceutical company focused on natural, herbal-based and homeopathic medicines. Comparable to OTX Force in its German-market B2B2C model with physicians and pharmacists, and in its portfolio of plant-derived medicinal products.
• Klosterfrau München GmbH: A traditional German manufacturer of herbal and natural OTC medicines (e.g., Klosterfrau Melissengeist). Direct peer in herbal OTC distribution through German pharmacies with a similar historical, family-owned heritage and phytopharmaceutical orientation.
• Dr. Willmar Schwabe Group: The parent company of OTX Force and a globally leading manufacturer of phytopharmaceutical medicines. It is the source of OTX Force's entire product portfolio (Lasea, Tebonin, Umckaloabo, Carmenthin, Refluthin) and the most directly comparable herbal-medicine business in the German market.

Broad incumbents

• Merck KGaA: A major German science and healthcare company operating across pharmaceuticals, life science tools, and electronics. Comparable as a German-headquartered healthcare incumbent with overlapping presence in physician channels and OTC-adjacent product categories, though its portfolio is not phytopharmaceutical-focused.
• Sanofi-Aventis Deutschland GmbH: The German subsidiary of global pharma major Sanofi, with a broad OTC and consumer health portfolio. Competes with OTX Force brands through pharmacist recommendation for indications such as cough/cold and anxiety, though from a much larger, synthetic-led portfolio.
• STADA Arzneimittel AG: A German-headquartered generics and specialty pharma company with a sizeable consumer health / OTC business distributed through German pharmacies. Comparable as a Germany-focused OTC distributor competing for the same pharmacy shelf and physician recommendation.
• Boehringer Ingelheim: A large German pharmaceutical company with respiratory and consumer health franchises. Overlaps with OTX Force in indications like bronchitis (Umckaloabo) and operates in the same German physician/pharmacy channel, but as a much broader, mostly synthetic-medicine player.
• Bayer AG: A global German pharmaceutical and consumer health company with a substantial OTC and consumer-care portfolio. Overlaps with OTX Force in the German OTC pharmacy channel but operates at much greater scale and across synthetic as well as natural products.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OTX Force